{"id":346229,"date":"2026-11-13T12:39:28","date_gmt":"2026-11-13T07:09:28","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=346229"},"modified":"2026-11-13T12:39:28","modified_gmt":"2026-11-13T07:09:28","slug":"pharmaceutical-ingredients-maker-multi-speciality-hospitals-group-and-tyres-maker-stocks-roadmap-escarpment-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/pharmaceutical-ingredients-maker-multi-speciality-hospitals-group-and-tyres-maker-stocks-roadmap-escarpment-list\/","title":{"rendered":"3 Pharmaceutical Ingredients Maker, Multi Speciality Hospitals Group and Tyres Maker Stocks With a Strong Future Roadmap: Granules India, Global Health and Apollo Tyres"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E84;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Granules India, Global Health and Apollo Tyres: ROE of 11.7% to 14.1% and FY22 to FY26 revenue CAGR of 7.9% to 19.6%. Prices as of 12 Nov 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E84;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">The three pharma ingredient, hospital and tyre stocks to watch are Granules India, Global Health and Apollo Tyres. Their return on equity ranges from 11.7% to 14.1%, and their revenue compound annual growth from FY22 to FY26 ranges from 7.9% to 19.6%. Global Health leads on both return on equity at 14.1% and revenue growth at 19.6% a year. Prices are based on the 12 November 2026 close, and this article is educational, not investment advice.<\/p>\n<\/div>\n<p>Pharma ingredient, hospital and tyre stocks give investors a way to track businesses that sit close to everyday demand in India. Granules India, Global Health and Apollo Tyres cover a pharmaceutical ingredients maker, a multi speciality hospitals group and a tyres maker.<\/p>\n<p>This list covers three pharma ingredient, hospital and tyre stocks with complete current figures: Granules India, Global Health and Apollo Tyres. Every figure comes from the latest reported financials and the 12 November 2026 market close. Companies without complete current figures were left out.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=pharmaceutical-ingredients-maker-multi-speciality-hospitals-group-and-tyres-maker-stocks-roadmap-escarpment-list\">Click Here &#8211; Get Free Investment Predictions<\/a><\/strong><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceutical-ingredients-maker-multi-speciality-hospitals-group-and-tyres-maker-stocks-roadmap-escarpment-list\/#What_Are_Pharma_Ingredient_Hospital_and_Tyre_Stocks\" title=\"What Are Pharma Ingredient, Hospital and Tyre Stocks?\">What Are Pharma Ingredient, Hospital and Tyre Stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceutical-ingredients-maker-multi-speciality-hospitals-group-and-tyres-maker-stocks-roadmap-escarpment-list\/#Pharma_Ingredient_Hospital_and_Tyre_Stocks_at_a_Glance\" title=\"Pharma Ingredient, Hospital and Tyre Stocks at a Glance\">Pharma Ingredient, Hospital and Tyre Stocks at a Glance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceutical-ingredients-maker-multi-speciality-hospitals-group-and-tyres-maker-stocks-roadmap-escarpment-list\/#Why_Do_Pharma_Ingredient_Hospital_and_Tyre_Stocks_Have_a_Strong_Roadmap_in_India\" title=\"Why Do Pharma Ingredient, Hospital and Tyre Stocks Have a Strong Roadmap in India?\">Why Do Pharma Ingredient, Hospital and Tyre Stocks Have a Strong Roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceutical-ingredients-maker-multi-speciality-hospitals-group-and-tyres-maker-stocks-roadmap-escarpment-list\/#Why_Granules_India_Features_Among_These_Pharma_Ingredient_Hospital_and_Tyre_Stocks\" title=\"Why Granules India Features Among These Pharma Ingredient, Hospital and Tyre Stocks\">Why Granules India Features Among These Pharma Ingredient, Hospital and Tyre Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceutical-ingredients-maker-multi-speciality-hospitals-group-and-tyres-maker-stocks-roadmap-escarpment-list\/#Why_Global_Health_Features_Among_These_Pharma_Ingredient_Hospital_and_Tyre_Stocks\" title=\"Why Global Health Features Among These Pharma Ingredient, Hospital and Tyre Stocks\">Why Global Health Features Among These Pharma Ingredient, Hospital and Tyre Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceutical-ingredients-maker-multi-speciality-hospitals-group-and-tyres-maker-stocks-roadmap-escarpment-list\/#Why_Apollo_Tyres_Features_Among_These_Pharma_Ingredient_Hospital_and_Tyre_Stocks\" title=\"Why Apollo Tyres Features Among These Pharma Ingredient, Hospital and Tyre Stocks\">Why Apollo Tyres Features Among These Pharma Ingredient, Hospital and Tyre Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceutical-ingredients-maker-multi-speciality-hospitals-group-and-tyres-maker-stocks-roadmap-escarpment-list\/#Granules_India_vs_Global_Health_vs_Apollo_Tyres_on_Key_Financials\" title=\"Granules India vs Global Health vs Apollo Tyres on Key Financials\">Granules India vs Global Health vs Apollo Tyres on Key Financials<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceutical-ingredients-maker-multi-speciality-hospitals-group-and-tyres-maker-stocks-roadmap-escarpment-list\/#Key_Risks_to_Check_Before_Investing_in_Pharma_Ingredient_Hospital_and_Tyre_Stocks\" title=\"Key Risks to Check Before Investing in Pharma Ingredient, Hospital and Tyre Stocks\">Key Risks to Check Before Investing in Pharma Ingredient, Hospital and Tyre Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceutical-ingredients-maker-multi-speciality-hospitals-group-and-tyres-maker-stocks-roadmap-escarpment-list\/#Final_Thoughts_on_Pharma_Ingredient_Hospital_and_Tyre_Stocks\" title=\"Final Thoughts on Pharma Ingredient, Hospital and Tyre Stocks\">Final Thoughts on Pharma Ingredient, Hospital and Tyre Stocks<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceutical-ingredients-maker-multi-speciality-hospitals-group-and-tyres-maker-stocks-roadmap-escarpment-list\/#What_are_pharma_ingredient_hospital_and_tyre_stocks\" title=\"What are pharma ingredient, hospital and tyre stocks?\">What are pharma ingredient, hospital and tyre stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceutical-ingredients-maker-multi-speciality-hospitals-group-and-tyres-maker-stocks-roadmap-escarpment-list\/#Which_pharma_ingredient_hospital_and_tyre_stocks_are_covered_in_this_list\" title=\"Which pharma ingredient, hospital and tyre stocks are covered in this list?\">Which pharma ingredient, hospital and tyre stocks are covered in this list?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceutical-ingredients-maker-multi-speciality-hospitals-group-and-tyres-maker-stocks-roadmap-escarpment-list\/#Why_do_pharma_ingredient_hospital_and_tyre_stocks_have_a_strong_future_roadmap_in_India\" title=\"Why do pharma ingredient, hospital and tyre stocks have a strong future roadmap in India?\">Why do pharma ingredient, hospital and tyre stocks have a strong future roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceutical-ingredients-maker-multi-speciality-hospitals-group-and-tyres-maker-stocks-roadmap-escarpment-list\/#How_has_Granules_India_performed_financially\" title=\"How has Granules India performed financially?\">How has Granules India performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceutical-ingredients-maker-multi-speciality-hospitals-group-and-tyres-maker-stocks-roadmap-escarpment-list\/#How_has_Global_Health_performed_financially\" title=\"How has Global Health performed financially?\">How has Global Health performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceutical-ingredients-maker-multi-speciality-hospitals-group-and-tyres-maker-stocks-roadmap-escarpment-list\/#How_has_Apollo_Tyres_performed_financially\" title=\"How has Apollo Tyres performed financially?\">How has Apollo Tyres performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceutical-ingredients-maker-multi-speciality-hospitals-group-and-tyres-maker-stocks-roadmap-escarpment-list\/#What_risks_should_investors_check_before_buying_pharma_ingredient_hospital_and_tyre_stocks\" title=\"What risks should investors check before buying pharma ingredient, hospital and tyre stocks?\">What risks should investors check before buying pharma ingredient, hospital and tyre stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceutical-ingredients-maker-multi-speciality-hospitals-group-and-tyres-maker-stocks-roadmap-escarpment-list\/#Is_this_list_of_pharma_ingredient_hospital_and_tyre_stocks_investment_advice\" title=\"Is this list of pharma ingredient, hospital and tyre stocks investment advice?\">Is this list of pharma ingredient, hospital and tyre stocks investment advice?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_Pharma_Ingredient_Hospital_and_Tyre_Stocks\"><\/span><strong>What Are Pharma Ingredient, Hospital and Tyre Stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Pharma ingredient, hospital and tyre stocks are listed companies that make active pharmaceutical ingredients and finished medicines, run large multi speciality hospitals, and make tyres for cars, trucks and farm vehicles. Their earnings depend on medicine demand, patient volumes and vehicle demand.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Pharma_Ingredient_Hospital_and_Tyre_Stocks_at_a_Glance\"><\/span><strong>Pharma Ingredient, Hospital and Tyre Stocks at a Glance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">CMP (Rs)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Industry P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">ROE (%)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">D\/E<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/granules\/granules-india-ltd-share-price-today\">Granules India<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">840.5<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">22,002<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">33.2<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">36.0<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">11.7<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.30<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/medanta\/global-health-ltd-share-price-today\">Global Health<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,439.7<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">33,277<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">60.3<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">59.6<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">14.1<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.30<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/apollotyre\/apollo-tyres-ltd-share-price-today\">Apollo Tyres<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">423.2<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">24,413<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">14.3<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">19.2<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">12.4<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.22<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>On valuation, Granules India and Apollo Tyres trade at a P\/E below the industry P\/E, while Global Health trades above it, which reflects the growth the market already expects. Readers comparing pharma ingredient, hospital and tyre stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain. With the Q2 FY27 results season close, investors in pharma ingredient, hospital and tyre stocks can use the coming numbers to test whether growth is holding.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Do_Pharma_Ingredient_Hospital_and_Tyre_Stocks_Have_a_Strong_Roadmap_in_India\"><\/span><strong>Why Do Pharma Ingredient, Hospital and Tyre Stocks Have a Strong Roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Pharma ingredient, hospital and tyre stocks have a strong roadmap in India because steady demand for essential medicines, rising need for quality specialist care and growing vehicle sales keep widening the market for these companies.<\/p>\n<ul>\n<li><strong>Pharma ingredients.<\/strong> Medicine makers need reliable supply.<\/li>\n<li><strong>Hospitals.<\/strong> Families seek quality specialist care.<\/li>\n<li><strong>Tyres.<\/strong> Vehicles need dependable tyres.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Why_Granules_India_Features_Among_These_Pharma_Ingredient_Hospital_and_Tyre_Stocks\"><\/span><strong>Why Granules India Features Among These Pharma Ingredient, Hospital and Tyre Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the pharma ingredient, hospital and tyre stocks on this list, Granules India is a Hyderabad-based pharmaceutical manufacturer that makes active ingredients, intermediates and finished dosage forms, with a strong position in paracetamol, metformin and ibuprofen.<\/p>\n<p>Revenue rose from Rs 3,783 crore in FY22 to Rs 5,386 crore in FY26, a compound annual growth rate of 9.2%. Net profit grew from Rs 413 crore in FY22 to Rs 595 crore in FY26, which works out to a compound annual growth rate of 9.6%.<\/p>\n<p>In the June 2026 quarter, revenue grew 20.6% year on year to Rs 1,479 crore, while net profit rose 59.8% to Rs 180 crore. The company has a return on equity of 11.7%, a debt to equity ratio of 0.30 and a market capitalisation of Rs 22,002 crore. The stock trades at a P\/E of 33.2, below the industry P\/E of 36.0.<\/p>\n<p><strong>Roadmap:<\/strong> The company is shifting its mix towards finished dosages, which earn better margins than ingredients, and it supplies customers in regulated markets, especially the United States. Capacity additions and new product approvals support steady growth.<\/p>\n<p><strong>What to watch:<\/strong> Monitor new product approvals and the share of finished dosages in total sales.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Global_Health_Features_Among_These_Pharma_Ingredient_Hospital_and_Tyre_Stocks\"><\/span><strong>Why Global Health Features Among These Pharma Ingredient, Hospital and Tyre Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the paracetamol, multi speciality care and truck tyre shares on this list, Global Health, which operates the Medanta brand, runs tertiary-care hospitals led by its flagship campus in Gurugram, along with facilities in Lucknow, Patna, Ranchi, Indore and Noida.<\/p>\n<p>In the June 2026 quarter, revenue grew 26.1% year on year to Rs 1,326 crore. Revenue rose from Rs 2,206 crore in FY22 to Rs 4,509 crore in FY26, a compound annual growth rate of 19.6%.<\/p>\n<p>Net profit grew from Rs 196 crore in FY22 to Rs 554 crore in FY26, which works out to a compound annual growth rate of 29.6%. The company has a return on equity of 14.1%, a debt to equity ratio of 0.30 and a market capitalisation of Rs 33,277 crore. The stock trades at a P\/E of 60.3, above the industry P\/E of 59.6.<\/p>\n<p><strong>Roadmap:<\/strong> Management is widening its reach in Tier 2 cities while adding capacity at the Gurugram campus. A broader doctor base and a rising share of complex procedures such as cardiac and transplant care support the earnings mix as new facilities mature.<\/p>\n<p><strong>What to watch:<\/strong> Watch the ramp-up speed of newer hospitals and the pace of doctor additions at each site.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Apollo_Tyres_Features_Among_These_Pharma_Ingredient_Hospital_and_Tyre_Stocks\"><\/span><strong>Why Apollo Tyres Features Among These Pharma Ingredient, Hospital and Tyre Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the three companies on this list, Apollo Tyres is an Indian tyre maker with plants in India and Europe that sells passenger car, truck and bus, two-wheeler, farm and off-highway tyres under the Apollo and Vredestein brands.<\/p>\n<p>The company has a return on equity of 12.4%, a debt to equity ratio of 0.22 and a market capitalisation of Rs 24,413 crore. The stock trades at a P\/E of 14.3, below the industry P\/E of 19.2.<\/p>\n<p>Revenue rose from Rs 21,071 crore in FY22 to Rs 28,604 crore in FY26, a compound annual growth rate of 7.9%. Net profit grew from Rs 639 crore in FY22 to Rs 1,372 crore in FY26, which works out to a compound annual growth rate of 21.1%. In the June 2026 quarter, revenue grew 13.3% year on year to Rs 7,456 crore.<\/p>\n<p><strong>Roadmap:<\/strong> The company is growing its premium and radial offerings and using its European presence to serve global customers. A strong dealer network in India supports replacement sales.<\/p>\n<p><strong>What to watch:<\/strong> Follow raw material costs, replacement demand and the performance of the European business.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Granules_India_vs_Global_Health_vs_Apollo_Tyres_on_Key_Financials\"><\/span><strong>Granules India vs Global Health vs Apollo Tyres on Key Financials<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table below sets the three pharma ingredient, hospital and tyre stocks side by side on revenue, profit and margin, using reported figures.<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY22 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Revenue CAGR (FY22-FY26)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Net Profit (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Net Margin<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Granules India<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">3,783<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">5,386<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">9.2%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">595<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">11.0%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Global Health<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">2,206<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">4,509<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">19.6%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">554<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">12.3%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Apollo Tyres<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">21,071<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">28,604<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">7.9%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,372<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">4.8%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>Global Health posts the highest return on equity in this group at 14.1%. Apollo Tyres has the largest FY26 revenue at Rs 28,604 crore, and Global Health shows the fastest revenue growth with a 19.6% compound annual rate. A useful habit with pharma ingredient, hospital and tyre stocks is to check each new quarterly result against the capacity plans the company described earlier.<\/p>\n<p>The June 2026 quarter, the latest reported, gives a fresh read on momentum:<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Q1 FY26 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Q1 FY27 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Year-on-Year Growth<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Granules India<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,226<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,479<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">20.6%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Global Health<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,051<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,326<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">26.1%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Apollo Tyres<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">6,580<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">7,456<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">13.3%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_Check_Before_Investing_in_Pharma_Ingredient_Hospital_and_Tyre_Stocks\"><\/span><strong>Key Risks to Check Before Investing in Pharma Ingredient, Hospital and Tyre Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Every theme carries risks that deserve a check before any decision. For these pharma ingredient, hospital and tyre stocks, the main points are: Long-term paracetamol, multi speciality care and truck tyre shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.<\/p>\n<ul>\n<li><strong>Regulatory approvals.<\/strong> Plant inspections and approvals can affect supplies.<\/li>\n<li><strong>Capacity ramp up.<\/strong> New hospitals take time to fill beds and reach full returns.<\/li>\n<li><strong>Raw material costs.<\/strong> Ingredient and packaging prices can move margins.<\/li>\n<\/ul>\n<p>Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/screeners\">Use the Univest Stock Screener<\/a><\/strong> to filter pharma ingredient, hospital and tyre stocks by market capitalisation, P\/E, ROE and growth, and build your own shortlist.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Final_Thoughts_on_Pharma_Ingredient_Hospital_and_Tyre_Stocks\"><\/span><strong>Final Thoughts on Pharma Ingredient, Hospital and Tyre Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Pharma ingredient, hospital and tyre stocks work best when investors track growth, valuation and return on equity side by side. Granules India, Global Health and Apollo Tyres each have a clear plan to grow. Based on the 12 November 2026 close, Granules India trades at Rs 840.5, Global Health at Rs 1,439.7 and Apollo Tyres at Rs 423.2. Valuation matters as much as growth, so compare each company&#8217;s P\/E with its industry P\/E before adding any of these pharma ingredient, hospital and tyre stocks to a watchlist.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track pharma ingredient, hospital and tyre stocks, set price alerts and get research-backed stock ideas.<\/em><\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h3><span class=\"ez-toc-section\" id=\"What_are_pharma_ingredient_hospital_and_tyre_stocks\"><\/span><strong>What are pharma ingredient, hospital and tyre stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Pharma ingredient, hospital and tyre stocks are listed companies that make active pharmaceutical ingredients and finished medicines, run large multi speciality hospitals, and make tyres for cars, trucks and farm vehicles. Their earnings depend on medicine demand, patient volumes and vehicle demand. This list looks at three of them, Granules India, Global Health and Apollo Tyres, using reported FY22 to FY26 financials and the 12 November 2026 closing prices.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_pharma_ingredient_hospital_and_tyre_stocks_are_covered_in_this_list\"><\/span><strong>Which pharma ingredient, hospital and tyre stocks are covered in this list?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> This list covers Granules India, Global Health and Apollo Tyres. Based on the 12 November 2026 close, Granules India traded at Rs 840.5, Global Health at Rs 1,439.7 and Apollo Tyres at Rs 423.2. Their return on equity ranges from 11.7% to 14.1%, and their revenue compound annual growth from FY22 to FY26 ranges from 7.9% to 19.6%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_do_pharma_ingredient_hospital_and_tyre_stocks_have_a_strong_future_roadmap_in_India\"><\/span><strong>Why do pharma ingredient, hospital and tyre stocks have a strong future roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Pharma ingredient, hospital and tyre stocks have a strong roadmap in India because steady demand for essential medicines, rising need for quality specialist care and growing vehicle sales keep widening the market for these companies. The main drivers are as follows. Pharma ingredients. Medicine makers need reliable supply. Hospitals. Families seek quality specialist care. Tyres. Vehicles need dependable tyres. Together these factors give the companies on this list a visible path for growth over the coming years.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Granules_India_performed_financially\"><\/span><strong>How has Granules India performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 3,783 crore in FY22 to Rs 5,386 crore in FY26, a compound annual growth rate of 9.2%. Net profit grew from Rs 413 crore in FY22 to Rs 595 crore in FY26, which works out to a compound annual growth rate of 9.6%. In the June 2026 quarter, revenue grew 20.6% year on year to Rs 1,479 crore, while net profit rose 59.8% to Rs 180 crore. The company has a return on equity of 11.7%, a debt to equity ratio of 0.30 and a market capitalisation of Rs 22,002 crore. The stock trades at a P\/E of 33.2, below the industry P\/E of 36.0. Looking ahead, the company is shifting its mix towards finished dosages, which earn better margins than ingredients, and it supplies customers in regulated markets, especially the United States. Capacity additions and new product approvals support steady growth.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Global_Health_performed_financially\"><\/span><strong>How has Global Health performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 2,206 crore in FY22 to Rs 4,509 crore in FY26, a compound annual growth rate of 19.6%. Net profit grew from Rs 196 crore in FY22 to Rs 554 crore in FY26, which works out to a compound annual growth rate of 29.6%. In the June 2026 quarter, revenue grew 26.1% year on year to Rs 1,326 crore. The company has a return on equity of 14.1%, a debt to equity ratio of 0.30 and a market capitalisation of Rs 33,277 crore. The stock trades at a P\/E of 60.3, above the industry P\/E of 59.6. Looking ahead, management is widening its reach in Tier 2 cities while adding capacity at the Gurugram campus. A broader doctor base and a rising share of complex procedures such as cardiac and transplant care support the earnings mix as new facilities mature.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Apollo_Tyres_performed_financially\"><\/span><strong>How has Apollo Tyres performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 21,071 crore in FY22 to Rs 28,604 crore in FY26, a compound annual growth rate of 7.9%. Net profit grew from Rs 639 crore in FY22 to Rs 1,372 crore in FY26, which works out to a compound annual growth rate of 21.1%. In the June 2026 quarter, revenue grew 13.3% year on year to Rs 7,456 crore. The company has a return on equity of 12.4%, a debt to equity ratio of 0.22 and a market capitalisation of Rs 24,413 crore. The stock trades at a P\/E of 14.3, below the industry P\/E of 19.2. Looking ahead, the company is growing its premium and radial offerings and using its European presence to serve global customers. A strong dealer network in India supports replacement sales.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_risks_should_investors_check_before_buying_pharma_ingredient_hospital_and_tyre_stocks\"><\/span><strong>What risks should investors check before buying pharma ingredient, hospital and tyre stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors should check a few risks before buying pharma ingredient, hospital and tyre stocks. Regulatory approvals. Plant inspections and approvals can affect supplies. Capacity ramp up. New hospitals take time to fill beds and reach full returns. Raw material costs. Ingredient and packaging prices can move margins. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_this_list_of_pharma_ingredient_hospital_and_tyre_stocks_investment_advice\"><\/span><strong>Is this list of pharma ingredient, hospital and tyre stocks investment advice?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No. This article is educational and uses publicly available data as of the 12 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What are pharma ingredient, hospital and tyre stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Pharma ingredient, hospital and tyre stocks are listed companies that make active pharmaceutical ingredients and finished medicines, run large multi speciality hospitals, and make tyres for cars, trucks and farm vehicles. Their earnings depend on medicine demand, patient volumes and vehicle demand. This list looks at three of them, Granules India, Global Health and Apollo Tyres, using reported FY22 to FY26 financials and the 12 November 2026 closing prices.\"}},{\"@type\":\"Question\",\"name\":\"Which pharma ingredient, hospital and tyre stocks are covered in this list?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"This list covers Granules India, Global Health and Apollo Tyres. Based on the 12 November 2026 close, Granules India traded at Rs 840.5, Global Health at Rs 1,439.7 and Apollo Tyres at Rs 423.2. Their return on equity ranges from 11.7% to 14.1%, and their revenue compound annual growth from FY22 to FY26 ranges from 7.9% to 19.6%.\"}},{\"@type\":\"Question\",\"name\":\"Why do pharma ingredient, hospital and tyre stocks have a strong future roadmap in India?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Pharma ingredient, hospital and tyre stocks have a strong roadmap in India because steady demand for essential medicines, rising need for quality specialist care and growing vehicle sales keep widening the market for these companies. The main drivers are as follows. Pharma ingredients. Medicine makers need reliable supply. Hospitals. Families seek quality specialist care. Tyres. Vehicles need dependable tyres. Together these factors give the companies on this list a visible path for growth over the coming years.\"}},{\"@type\":\"Question\",\"name\":\"How has Granules India performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 3,783 crore in FY22 to Rs 5,386 crore in FY26, a compound annual growth rate of 9.2%. Net profit grew from Rs 413 crore in FY22 to Rs 595 crore in FY26, which works out to a compound annual growth rate of 9.6%. In the June 2026 quarter, revenue grew 20.6% year on year to Rs 1,479 crore, while net profit rose 59.8% to Rs 180 crore. The company has a return on equity of 11.7%, a debt to equity ratio of 0.30 and a market capitalisation of Rs 22,002 crore. The stock trades at a P\/E of 33.2, below the industry P\/E of 36.0. Looking ahead, the company is shifting its mix towards finished dosages, which earn better margins than ingredients, and it supplies customers in regulated markets, especially the United States. Capacity additions and new product approvals support steady growth.\"}},{\"@type\":\"Question\",\"name\":\"How has Global Health performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 2,206 crore in FY22 to Rs 4,509 crore in FY26, a compound annual growth rate of 19.6%. Net profit grew from Rs 196 crore in FY22 to Rs 554 crore in FY26, which works out to a compound annual growth rate of 29.6%. In the June 2026 quarter, revenue grew 26.1% year on year to Rs 1,326 crore. The company has a return on equity of 14.1%, a debt to equity ratio of 0.30 and a market capitalisation of Rs 33,277 crore. The stock trades at a P\/E of 60.3, above the industry P\/E of 59.6. Looking ahead, management is widening its reach in Tier 2 cities while adding capacity at the Gurugram campus. A broader doctor base and a rising share of complex procedures such as cardiac and transplant care support the earnings mix as new facilities mature.\"}},{\"@type\":\"Question\",\"name\":\"How has Apollo Tyres performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 21,071 crore in FY22 to Rs 28,604 crore in FY26, a compound annual growth rate of 7.9%. Net profit grew from Rs 639 crore in FY22 to Rs 1,372 crore in FY26, which works out to a compound annual growth rate of 21.1%. In the June 2026 quarter, revenue grew 13.3% year on year to Rs 7,456 crore. The company has a return on equity of 12.4%, a debt to equity ratio of 0.22 and a market capitalisation of Rs 24,413 crore. The stock trades at a P\/E of 14.3, below the industry P\/E of 19.2. Looking ahead, the company is growing its premium and radial offerings and using its European presence to serve global customers. A strong dealer network in India supports replacement sales.\"}},{\"@type\":\"Question\",\"name\":\"What risks should investors check before buying pharma ingredient, hospital and tyre stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Investors should check a few risks before buying pharma ingredient, hospital and tyre stocks. Regulatory approvals. Plant inspections and approvals can affect supplies. Capacity ramp up. New hospitals take time to fill beds and reach full returns. Raw material costs. Ingredient and packaging prices can move margins. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.\"}},{\"@type\":\"Question\",\"name\":\"Is this list of pharma ingredient, hospital and tyre stocks investment advice?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No. This article is educational and uses publicly available data as of the 12 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Pharma Ingredient, Hospital and Tyre Stocks with a strong future roadmap: Granules India, Global Health and Apollo Tyres. Compare price, valuation, return on equity and revenue growth as of 12 November 2026.<\/p>\n","protected":false},"author":34,"featured_media":346228,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[19524,3812,3803,7544,9050,23514,23512,23513,20326,17319],"class_list":["post-346229","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-api-maker","tag-apollo-tyres","tag-best-stocks","tag-global-health","tag-granules-india","tag-healthcare-group-and-rubber-tyre-stocks","tag-hospital-and-tyre-stocks","tag-multi-speciality-care-and-truck-tyre-shares","tag-paracetamol","tag-pharma-ingredient"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["346228"],"rank_math_title":["Pharma Ingredient, Hospital and Tyre Stocks"],"rank_math_description":["Compare 3 pharma ingredient, hospital and tyre stocks with a strong future roadmap on CMP, market cap, P\/E, ROE and revenue growth. Data as of 12 Nov 2026."],"rank_math_focus_keyword":["pharma ingredient, hospital and tyre stocks"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/11\/3-pharmaceutical-ingredients-maker-multi-speciality-hospitals-group-and-tyres.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/346229","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/34"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=346229"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/346229\/revisions"}],"predecessor-version":[{"id":346230,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/346229\/revisions\/346230"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/346228"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=346229"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=346229"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=346229"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}